General MedicationsORALGeneric
MINIZIDE
POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE
Standard Dose
0.5MG;EQ 1MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview MINIZIDE is listed in Drugs@FDA under application 017986 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE Form and strength CAPSULE;ORAL - 0.5MG;EQ 1MG BASE Sponsor PFIZER Submission history Latest submission status date: 1994-05-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview MINIZIDE is listed in Drugs@FDA under application 017986 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE Form and strength CAPSULE;ORAL - 0.5MG;EQ 1MG BASE Sponsor PFIZER Submission history Latest submission status date: 1994-05-10 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.